Design, data analysis, and simulation of in vitro drug transport kinetic experiments using a mechanistic in vitro model.
about
ITC recommendations for transporter kinetic parameter estimation and translational modeling of transport-mediated PK and DDIs in humansSimultaneous assessment of uptake and metabolism in rat hepatocytes: a comprehensive mechanistic modelReduced physiologically-based pharmacokinetic model of repaglinide: impact of OATP1B1 and CYP2C8 genotype and source of in vitro data on the prediction of drug-drug interaction risk.Prediction of hepatic clearance in human from in vitro data for successful drug development.A systems biology approach to dynamic modeling and inter-subject variability of statin pharmacokinetics in human hepatocytes.Quantification of fexofenadine in biological matrices: a review of bioanalytical methods.Pharmacokinetic/Pharmacodynamic predictors of clinical potency for hepatitis C virus nonnucleoside polymerase and protease inhibitors.Role of the intestinal peptide transporter PEPT1 in oseltamivir absorption: in vitro and in vivo studies.Elucidation of the Mechanisms through Which the Reactive Metabolite Diclofenac Acyl Glucuronide Can Mediate Toxicity.A mechanistic framework for in vitro-in vivo extrapolation of liver membrane transporters: prediction of drug-drug interaction between rosuvastatin and cyclosporineHuman clearance prediction: shifting the paradigm.Computational approaches to analyse and predict small molecule transport and distribution at cellular and subcellular levelsDifferences in amyloid-β clearance across mouse and human blood-brain barrier models: kinetic analysis and mechanistic modeling.Primary hepatocyte cultures as prominent in vitro tools to study hepatic drug transporters.In vitro and in vivo approaches to characterize transporter-mediated disposition in drug discovery.Physiologically based pharmacokinetic modeling in drug discovery and development: a pharmaceutical industry perspective.Predicting Transport of 3,5,6-Trichloro-2-Pyridinol Into Saliva Using a Combination Experimental and Computational Approach.Thyroid hormone (levothyroxine) replacement via the respiratory route by inhalation: in vitro exploratory studies.Defining and Controlling Exposure During In Vitro Toxicity Testing and the Potential of Passive Dosing.Upregulation of sodium taurocholate cotransporter polypeptide during hepatogenic differentiation of umbilical cord matrix mesenchymal stem cells facilitates hepatitis B entry.Characterization of the transmembrane transport and absolute bioavailability of the HCV protease inhibitor danoprevir.Use of mechanistic modeling to assess interindividual variability and interspecies differences in active uptake in human and rat hepatocytesEffects of Trichostatin A on drug uptake transporters in primary rat hepatocyte cultures.Experimental and mathematical analysis of in vitro Pitavastatin hepatic uptake across species.Role of the OATP Transporter Family and a Benzbromarone-SensitiveEfflux Transporter in the Hepatocellular Disposition of Vincristine.Evaluation of transporter-mediated hepatic uptake in a non-radioactive high-throughput assay: a study of kinetics, species difference and plasma protein effect.Cytosolic Uptake of Large Monofunctionalized Dextrans.Dissecting the relative contribution of OATP1B1-mediated uptake of xenobiotics into human hepatocytes using siRNA
P2860
Q27022933-5754AED5-8EB0-4DA7-8060-98D0BE3C4816Q30511951-5B0EE044-B207-4698-AD9F-70C660A9F9C4Q30776360-037B02ED-E574-4D9B-8B36-9F77E920900CQ33437736-A02F599F-F7AF-46A7-A6E6-D63C49FDF1B8Q33891588-BEB7E579-5B26-4C4D-95A8-8B5966E327F1Q34166009-B54571E6-EEE1-473C-8B7C-2402A680A149Q36018848-3FEE57E6-25F4-4D13-84D0-F69A6245A9A4Q36105344-29C97859-34BB-4BAD-AFC4-0BD3BC49ED63Q36733518-2049ED9E-535F-4963-96FC-9A9A29C13435Q37470663-5F869500-EE00-4BD2-B9BA-82312F601A0BQ37554400-D5440240-14C8-4689-B706-D87429EBC995Q37626169-24A68A9B-1B64-44DC-AE97-04F513AE5A7EQ37662438-9D61B712-CEBE-42A6-9BBB-B67435F513A4Q38077993-2768EAE1-F56E-48E2-B617-C05977BC9894Q38214334-A7FAA06B-4AE1-42C5-BA78-6182F046F9D4Q38351385-E40AD5D7-BF2B-45E7-A7E5-D07AE718DD6CQ38731361-A0947768-8DD7-4D8F-B082-8FFA861AE9BAQ38810550-667ECF28-F05B-49B7-B3DE-E51B1D6807CDQ38894327-5806ACB1-58AC-4CAC-A41A-9D248423C69FQ41927740-C882102D-B9CB-4E29-A27A-75B9D59C7B9DQ42177328-28FBD3A6-E886-4193-8831-13ACD7DFD893Q42282480-90BB600D-43C1-4A91-9974-BC72504A25A8Q43143296-47D58A2B-BEC6-46E6-BE92-1F6E85914DCAQ43772347-43725DA6-E76A-4209-9624-DBCAD57B8F9FQ46318141-B4D72C06-7704-45DD-B2A5-5513262B020DQ47212461-692127A0-C84F-48A2-B3BA-A177BD8A21C8Q52591784-1AF77657-EBB3-499D-8625-0850E6B06682Q58073588-9B6539E6-8972-4C45-A881-182E92FEFD90
P2860
Design, data analysis, and simulation of in vitro drug transport kinetic experiments using a mechanistic in vitro model.
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Design, data analysis, and sim ...... a mechanistic in vitro model.
@ast
Design, data analysis, and sim ...... a mechanistic in vitro model.
@en
type
label
Design, data analysis, and sim ...... a mechanistic in vitro model.
@ast
Design, data analysis, and sim ...... a mechanistic in vitro model.
@en
prefLabel
Design, data analysis, and sim ...... a mechanistic in vitro model.
@ast
Design, data analysis, and sim ...... a mechanistic in vitro model.
@en
P2093
P356
P1476
Design, data analysis, and sim ...... a mechanistic in vitro model.
@en
P2093
Agnès Poirier
Christoph Funk
Frank Senner
Hans-Peter Grimm
Manfred Kansy
Marie-Elise Brun
Renée Portmann
Thierry Lavé
P304
P356
10.1124/DMD.108.020750
P577
2008-09-22T00:00:00Z